Tuesday, May 14, 2024 5:46:46 AM
TA, apparently you and noneyabiz over there, along with madg and myself over here FOR YEARS have been sounding the alarm. Meanwhile, the company's revs have increased all the way up by about 150k (While expenses have gone up 105k) on income that is STILL UNDER 1 million (YOY), along with over 100 million shares of dilution in a 2 month period....and...some THINK there is a concerted effort here concerning stock price? Unbelievable! How many years has this been in existence? How many years has Bal been running this? How important is this product? And yet....can't even pull in a million in revs (not counting the cost to pull in those revs). Again, unbelievable....but then again it isn't.
And now we're probably going for 1 to 300 reverse, with a slight chance at a little less. I won't even begin to try and figure out WHY Maxim or whomever is ALLOWED to short shares from the outset when I've personally seen OTHER companies FORCE the lenders/ buyers to wait at least 6 months before selling. The simple question would be: why can SOME companies call some of the shots, and others can't? But then again, if you're always the victim.....
And now we're probably going for 1 to 300 reverse, with a slight chance at a little less. I won't even begin to try and figure out WHY Maxim or whomever is ALLOWED to short shares from the outset when I've personally seen OTHER companies FORCE the lenders/ buyers to wait at least 6 months before selling. The simple question would be: why can SOME companies call some of the shots, and others can't? But then again, if you're always the victim.....
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
